Nervin Lawendy

Extraintestinal Manifestations at Baseline, and Effect of Tofacitinib in Patients With Moderate to Severe Ulcerative Colitis in the OCTAVE Program

BACKGROUND: Extraintestinal manifestations (EIMs) occur in approximately one-third of patients with ulcerative colitis (UC) (1). Tofacitinib is an oral, small molecule JAK inhibitor for t...

Paulo Gustavo Kotze ;

David T. Rubin , MD;

Marcia Pinheiro ;

Gary R. Lichtenstein ;

Haiyun Fan ;

Walter Reinisch ;

Marc Fellmann ;

Irene Modesto ;

Nervin Lawendy ;

Eric Maller ;

Thomas Greuter ;

Stephen Vavricka ;

12/12/2019

Featured Webinar

Implementing ERAS Protocols Throughout Patient Peri-Op Journey: Reductions in Complications

Upcoming Events

October 29 ⁠–⁠ November 2

November 1 ⁠–⁠ November 2

November 6 ⁠–⁠ November 8

November 7 ⁠–⁠ November 10

November 8 ⁠–⁠ November 10

November 8

November 13 ⁠–⁠ November 16

November 14 ⁠–⁠ November 15

November 23 ⁠–⁠ November 24

December 4 ⁠–⁠ December 5

See Full Calendar

Nervin Lawendy

Featured Webinar

Upcoming Events

Specialties

Events

Year Round Education

HMP Global Products